HOOKIPA Pharma Inc. (HOOK) symbol metrics page

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Hookipa Pharma Inc. (HOOK) NASDAQ

$0.84 0.07 (9.75%)

Market Cap: $73.86M

As of 04/24/24 03:07 PM EDT. Market open.

(HOOK)

Hookipa Pharma Inc. (HOOK)
NASDAQ

$0.84
0.07 (9.75%)

Market Cap: $73.86M

As of 04/24/24 03:07 PM EDT. Market open.

Add to Portfolio

hookipa pharma inc. is a clinical stage company developing products to prevent and cure infectious diseases and cancer. with this goal in mind we created unique and cutting-edge technologies which reprogram and stimulate the immune system. our arenavirus technologies, vaxwave®, a replication-deficient viral vector, and therat®, an attenuated replicating vector, induce potent ... read more

COMPANY PROFILE

Sector

Professional, Scientific, and Technical Services

Industry

Research and Development in Biotechnology

CEO Compensation (Base)

$361,600

CEO Compensation (Total)

$574,306

URL

hookipabiotech.com

Address

.

Sector

Professional, Scientific, and Technical Services

Industry

Research and Development in Biotechnology

Full Time Employees

133

CEO Compensation (Base)

$361,600

CEO Compensation (Total)

$574,306

URL

hookipabiotech.com

Address

.

PRICE CHART FOR HOOKIPA PHARMA INC

1w

1m

3m

6m

YTD

1y

5y

MAX

From: To:

NEWS

INSIDEARBITRAGE ARTICLES

KEY STATS

Open

$0.84

Previous Close

$0.77

Days Range

$0.73 - $0.80

52 week range

$0.41 - $2.05

Volume

9,760,763

Avg. Volume (30 days)

581,041

Market Cap

$73.86M

Dividend Yield

-

P/E

(0.91)

Shares Outstanding

96,550,590

Open

$0.84

Previous Close

$0.77

Days Range

$0.73 - $0.80

52 week range

$0.41 - $2.05

Volume

9,760,763

Avg. Volume (30 days)

581,041

Market Cap

$73.86M

Dividend Yield

-

P/E

(0.91)

Shares Outstanding

96,550,590

FINANCIAL STATEMENTS FOR HOOKIPA PHARMA INC

LOADING...

Open in:

Open in:

INSIDER TRANSACTIONS FOR HOOKIPA PHARMA INC

Owner	Relationship	Date	Transaction	Cost	# Shares	Value($)	Total Shares	Form 4
Kandera Reinhard	Chief Financial Officer	Aug 21, 2023	Buy	$0.73	7,000	5,075	43,092	Aug 22, 2023, 04:01 PM
Kandera Reinhard	Chief Financial Officer	Aug 16, 2023	Buy	$0.71	8,000	5,712	36,092	Aug 17, 2023, 04:05 PM
Aldag Jorn	Chief Executive Officer	Jul 11, 2023	Buy	$0.83	5,000	4,142	71,952	Jul 11, 2023, 06:21 PM
Aldag Jorn	Chief Executive Officer	Jul 07, 2023	Buy	$0.81	5,000	4,050	66,952	Jul 11, 2023, 06:21 PM
Aldag Jorn	Chief Executive Officer	Jul 05, 2023	Buy	$0.89	5,000	4,450	61,952	Jul 07, 2023, 05:06 PM
Aldag Jorn	Chief Executive Officer	Jul 03, 2023	Buy	$0.89	5,000	4,455	56,952	Jul 05, 2023, 07:37 PM
Kandera Reinhard	Chief Financial Officer	Jun 30, 2023	Buy	$0.88	12,000	10,560	28,092	Jul 03, 2023, 04:06 PM
Orlinger Klaus	Executive VP, Research	Feb 01, 2022	Option Exercise	$3.00	9,188	27,564	10,404	Feb 01, 2022, 08:52 PM
Baker Christine D.	Chief Business Officer	Feb 01, 2022	Option Exercise	$3.00	13,658	40,974	16,158	Feb 01, 2022, 08:50 PM
Necina Roman	Chief Technology Officer	Feb 01, 2022	Option Exercise	$3.00	12,892	38,676	14,876	Feb 01, 2022, 08:50 PM
Matushansky Igor	Chief Medical Officer	Feb 01, 2022	Option Exercise	$3.00	14,933	44,799	100,240	Feb 01, 2022, 08:49 PM
Kandera Reinhard	Chief Financial Officer	Feb 01, 2022	Option Exercise	$3.00	14,056	42,168	16,092	Feb 01, 2022, 08:48 PM
Aldag Jorn	Chief Executive Officer	Feb 01, 2022	Option Exercise	$3.00	47,824	143,472	51,952	Feb 01, 2022, 08:44 PM
Matushansky Igor	Chief Medical Officer	Dec 21, 2021	Option Exercise	$0.10	22,853	2,285	91,544	Jan 12, 2022, 10:07 AM
Matushansky Igor	Chief Medical Officer	Dec 21, 2021	Sale	$2.49	14,949	37,223	85,307	Jan 12, 2022, 10:07 AM
SOFINNOVA CAPITAL VI FCPR	10% Owner	Apr 21, 2021	Sale	$11.60	328,620	3,812,386	3,177,574	Apr 23, 2021, 04:30 PM
SOFINNOVA CAPITAL VI FCPR	10% Owner	Mar 29, 2021	Sale	$13.67	36,829	503,570	3,506,194	Mar 31, 2021, 04:06 PM
SOFINNOVA CAPITAL VI FCPR	10% Owner	Mar 26, 2021	Sale	$13.69	35,171	481,642	3,543,023	Mar 31, 2021, 06:01 AM
SOFINNOVA CAPITAL VI FCPR	10% Owner	Mar 25, 2021	Sale	$13.12	28,546	374,569	3,578,194	Mar 29, 2021, 04:01 PM
SOFINNOVA CAPITAL VI FCPR	10% Owner	Mar 24, 2021	Sale	$13.70	52,690	721,616	3,606,740	Mar 26, 2021, 07:12 PM
SOFINNOVA CAPITAL VI FCPR	10% Owner	Mar 23, 2021	Sale	$13.91	40,000	556,476	3,659,430	Mar 25, 2021, 06:13 PM
SOFINNOVA CAPITAL VI FCPR	10% Owner	Mar 22, 2021	Sale	$14.54	40,534	589,263	3,699,430	Mar 24, 2021, 06:16 PM
SOFINNOVA CAPITAL VI FCPR	10% Owner	Mar 19, 2021	Sale	$14.60	166,230	2,427,739	3,739,964	Mar 23, 2021, 04:31 PM
Matushansky Igor	Chief Medical Officer	Dec 16, 2020	Option Exercise	$0.10	640	64	56,774	Dec 18, 2020, 04:04 PM
Matushansky Igor	Chief Medical Officer	Dec 17, 2020	Option Exercise	$0.10	48,988	4,899	93,881	Dec 18, 2020, 04:04 PM
Matushansky Igor	Chief Medical Officer	Dec 16, 2020	Sale	$11.70	380	4,446	56,394	Dec 18, 2020, 04:04 PM
Matushansky Igor	Chief Medical Officer	Dec 17, 2020	Sale	$11.74	27,979	328,343	77,403	Dec 18, 2020, 04:04 PM
SOFINNOVA CAPITAL VI FCPR	10% Owner	Oct 02, 2020	Sale	$10.00	300	3,000	3,906,194	Oct 06, 2020, 04:01 PM
SOFINNOVA CAPITAL VI FCPR	10% Owner	Sep 15, 2020	Sale	$12.61	41,597	524,477	3,915,755	Sep 17, 2020, 04:02 PM
SOFINNOVA CAPITAL VI FCPR	10% Owner	Jun 29, 2020	Sale	$11.78	3,280	38,628	3,960,574	Jul 24, 2020, 05:07 PM
SOFINNOVA CAPITAL VI FCPR	10% Owner	Jun 29, 2020	Sale	$11.78	3,280	38,628	3,960,574	Jul 22, 2020, 04:03 PM
SOFINNOVA CAPITAL VI FCPR	10% Owner	Jul 20, 2020	Sale	$11.94	12,483	149,102	3,948,091	Jul 22, 2020, 04:03 PM
SOFINNOVA CAPITAL VI FCPR	10% Owner	Jun 29, 2020	Sale	$11.78	3,280	38,628	3,960,574	Jul 01, 2020, 04:16 PM
Matushansky Igor	Chief Medical Officer	Jan 29, 2020	Sale	$12.73	5,500	69,992	53,398	Jan 31, 2020, 04:01 PM
Lilja Anders	Sr. VP, Technical Development	Jan 23, 2020	Option Exercise	$0.10	11,643	1,164	7,568	Jan 27, 2020, 04:52 PM
Lilja Anders	Sr. VP, Technical Development	Jan 23, 2020	Sale	$12.59	11,643	146,533	0	Jan 27, 2020, 04:52 PM
Orlinger Klaus	Sr. VP, Research	Jan 16, 2020	Option Exercise	$0.10	1,711	171	1,711	Jan 21, 2020, 04:44 PM
Orlinger Klaus	Sr. VP, Research	Jan 21, 2020	Option Exercise	$0.10	6,789	679	6,789	Jan 21, 2020, 04:44 PM
Orlinger Klaus	Sr. VP, Research	Jan 16, 2020	Sale	$11.56	1,711	19,781	0	Jan 21, 2020, 04:44 PM
Orlinger Klaus	Sr. VP, Research	Jan 21, 2020	Sale	$12.02	6,789	81,592	0	Jan 21, 2020, 04:44 PM
Orlinger Klaus	Sr. VP, Research	Jan 14, 2020	Option Exercise	$0.10	8,500	850	8,500	Jan 16, 2020, 04:06 PM
Orlinger Klaus	Sr. VP, Research	Jan 14, 2020	Sale	$11.30	8,500	96,053	0	Jan 16, 2020, 04:06 PM
Matushansky Igor	Chief Medical Officer	Dec 19, 2019	Option Exercise	$0.10	25,891	2,589	69,302	Dec 23, 2019, 08:30 AM
Matushansky Igor	Chief Medical Officer	Dec 19, 2019	Sale	$9.93	10,404	103,312	58,898	Dec 23, 2019, 08:30 AM
Matushansky Igor	Chief Medical Officer	Dec 17, 2019	Option Exercise	$0.10	26,312	2,631	54,895	Dec 19, 2019, 04:03 PM
Matushansky Igor	Chief Medical Officer	Dec 17, 2019	Sale	$7.87	11,484	90,379	43,411	Dec 19, 2019, 04:03 PM
Forbion Capital Fund II Cooperatief U.A.	10% Owner	Apr 23, 2019	Buy	$14.00	53,571	749,994	2,494,173	Apr 25, 2019, 04:15 PM
SOFINNOVA CAPITAL VI FCPR	10% Owner	Apr 23, 2019	Buy	$14.00	357,142	4,999,988	3,963,854	Apr 25, 2019, 04:15 PM
BAKER BROS. ADVISORS LP	Former 10% owner	Apr 23, 2019	Buy	$14.00	892,857	12,499,998	820,729	Apr 23, 2019, 04:54 PM

Load More Insider Transactions

Buy Sale Option Exercise

Owner	Relationship	Date	Value($)
Kandera Reinhard	Chief Financial Officer	08/21/2023	5,075
Kandera Reinhard	Chief Financial Officer	08/16/2023	5,712
Aldag Jorn	Chief Executive Officer	07/11/2023	4,142
Aldag Jorn	Chief Executive Officer	07/07/2023	4,050
Aldag Jorn	Chief Executive Officer	07/05/2023	4,450
Aldag Jorn	Chief Executive Officer	07/03/2023	4,455
Kandera Reinhard	Chief Financial Officer	06/30/2023	10,560
Orlinger Klaus	Executive VP, Research	02/01/2022	27,564
Baker Christine D.	Chief Business Officer	02/01/2022	40,974
Necina Roman	Chief Technology Officer	02/01/2022	38,676
Matushansky Igor	Chief Medical Officer	02/01/2022	44,799
Kandera Reinhard	Chief Financial Officer	02/01/2022	42,168
Aldag Jorn	Chief Executive Officer	02/01/2022	143,472
Matushansky Igor	Chief Medical Officer	12/21/2021	2,285
Matushansky Igor	Chief Medical Officer	12/21/2021	37,223
SOFINNOVA CAPITAL VI FCPR	10% Owner	04/21/2021	3,812,386
SOFINNOVA CAPITAL VI FCPR	10% Owner	03/29/2021	503,570
SOFINNOVA CAPITAL VI FCPR	10% Owner	03/26/2021	481,642
SOFINNOVA CAPITAL VI FCPR	10% Owner	03/25/2021	374,569
SOFINNOVA CAPITAL VI FCPR	10% Owner	03/24/2021	721,616
SOFINNOVA CAPITAL VI FCPR	10% Owner	03/23/2021	556,476
SOFINNOVA CAPITAL VI FCPR	10% Owner	03/22/2021	589,263
SOFINNOVA CAPITAL VI FCPR	10% Owner	03/19/2021	2,427,739
Matushansky Igor	Chief Medical Officer	12/16/2020	64
Matushansky Igor	Chief Medical Officer	12/17/2020	4,899
Matushansky Igor	Chief Medical Officer	12/16/2020	4,446
Matushansky Igor	Chief Medical Officer	12/17/2020	328,343
SOFINNOVA CAPITAL VI FCPR	10% Owner	10/02/2020	3,000
SOFINNOVA CAPITAL VI FCPR	10% Owner	09/15/2020	524,477
SOFINNOVA CAPITAL VI FCPR	10% Owner	06/29/2020	38,628
SOFINNOVA CAPITAL VI FCPR	10% Owner	06/29/2020	38,628
SOFINNOVA CAPITAL VI FCPR	10% Owner	07/20/2020	149,102
SOFINNOVA CAPITAL VI FCPR	10% Owner	06/29/2020	38,628
Matushansky Igor	Chief Medical Officer	01/29/2020	69,992
Lilja Anders	Sr. VP, Technical Development	01/23/2020	1,164
Lilja Anders	Sr. VP, Technical Development	01/23/2020	146,533
Orlinger Klaus	Sr. VP, Research	01/16/2020	171
Orlinger Klaus	Sr. VP, Research	01/21/2020	679
Orlinger Klaus	Sr. VP, Research	01/16/2020	19,781
Orlinger Klaus	Sr. VP, Research	01/21/2020	81,592
Orlinger Klaus	Sr. VP, Research	01/14/2020	850
Orlinger Klaus	Sr. VP, Research	01/14/2020	96,053
Matushansky Igor	Chief Medical Officer	12/19/2019	2,589
Matushansky Igor	Chief Medical Officer	12/19/2019	103,312
Matushansky Igor	Chief Medical Officer	12/17/2019	2,631
Matushansky Igor	Chief Medical Officer	12/17/2019	90,379
Forbion Capital Fund II Cooperatief U.A.	10% Owner	04/23/2019	749,994
SOFINNOVA CAPITAL VI FCPR	10% Owner	04/23/2019	4,999,988
BAKER BROS. ADVISORS LP	Former 10% owner	04/23/2019	12,499,998

Load More Insider Transactions

FUNDS WITH A POSITION IN HOOKIPA PHARMA INC

Fund	# Shares Owned	% of Portfolio	% Change	Investing Style
BAKER BROS. ADVISORS LP	8,128,151	0.07%	0.78%	Other
GEODE CAPITAL MANAGEMENT, LLC	585,607	0.00005%	9.85%	Other
BLACKROCK INC.	294,272	0.00001%	-0.33%	Other
RENAISSANCE TECHNOLOGIES LLC	188,646	0.00024%	-66.05%	Other

CHANGE IN SHARES OUTSTANDING FOR HOOKIPA PHARMA INC

STOCK BUYBACKS FOR HOOKIPA PHARMA INC

Period of Report

Previous Period

% Change in Shares

10-K/10-Q Filings

Quarter

12/31/2023

09/30/2023

0%

1Q

12/31/2023

09/30/2022

53.46%

5Q

12/31/2023

06/30/2022

53.49%

6Q

12/31/2023

03/31/2022

53.51%

7Q

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period

% Change in Shares

Quarter

09/30/2023

0%

1Q

09/30/2022

53.46%

5Q

06/30/2022

53.49%

6Q

03/31/2022

53.51%

7Q

BUYBACK ANNOUNCEMENT(S) FOR HOOKIPA PHARMA INC

Active Completed

LOADING...